ABRAXANE
Abraxane (Paclitaxel Protein-Bound) is an FDA-approved chemotherapy infusion therapy used for the treatment of breast cancer, non-small cell lung cancer (NSCLC), and pancreatic cancer in adult patients. Each 1×1 EA powder vial contains Paclitaxel Protein-Bound, formulated for intravenous administration after reconstitution under professional supervision.
Abraxane works by stabilizing microtubules and inhibiting their disassembly, which prevents cancer cell division and leads to tumor cell death. This protein-bound formulation allows for solvent-free infusion, improving tolerability and reducing hypersensitivity reactions compared to conventional paclitaxel.
InfusionMed USA, headquartered in Carrollton, Texas, supplies Abraxane and other oncology infusion therapies to hospitals, clinics, and infusion centers across Dallas, McKinney, Frisco, Plano, Lewisville, The Colony, and surrounding North Texas areas. We ensure cold-chain compliance, proper handling, and timely delivery for licensed healthcare providers.
For professional use only.
Download Form